期刊文献+

奥沙利铂或依立替康联合卡培他滨治疗晚期大肠癌 被引量:1

下载PDF
导出
出处 《中国癌症杂志》 CAS CSCD 2007年第6期503-505,共3页 China Oncology
  • 相关文献

参考文献10

  • 1Hoff PM,Ansari R,Batist G,et al.Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first line treatment in 605 patients with metastatic colorectal cancer:resuhs of a randomized phase Ⅲ study[J].J Clin Oncol,2001,19(8):2282-2292.
  • 2张湘茹,孙燕,李青.抗癌新药奥沙利铂治疗晚期大肠癌[J].中国新药杂志,1998,7(4):266-269. 被引量:13
  • 3Advanced Colorectal Cancer Meta-Analysis Project.Modulation of fluorouracil by leucovofin in patients with advanced colorectal cancer:evidence in terms of response rate[J].J Clin Oncol,1992,10(6):896-903.
  • 4Douillard JY,Cunningham D,Roth AD,et al.Irinotecan combined with fluorouracil compared with fluorouracil alone as firstline treatment for metastatic colorectal cancer:a muhicentre randomized trial[J].Lancet,2000,355(9209):1041-1047.
  • 5De Gramont A,Figer A,Seymour M,et al.Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced eolorectal cancer[J].J Clin Oncol,2000,18(16):2938-2947.
  • 6Cutsem EV,Hoff PM,Harper P,et al.Oral capecitabine vs intravenous 5-fluorouracil and leucovorin:integrated efficacy data and novel analyses from two large,randomized,phase Ⅲ trials[J].Br J Cancer,2004,90(6):1190-1197.
  • 7Cassidy J,Tabemero J,Twelves C,et al.XELOX (capecitabine plus oxaliplatin):active first-line therapy for patients with metastatic colorectal cancer[J].J Clin Oncol,2004,22(11):2084-2091.
  • 8Sastre J,Massuti B,Tabernero JM,et al.Preliminary results of a randomized phase Ⅲ trial of the TTD Group comparing capecitabine and oxaliplatin (CapeOx) vs oxaliplatin and 5-fluorouracil in continuous infusion (5-FU CI)as first line treatment in advanced or metastatic colorectal cancer (CRC) (Abstr)[J].J Clin Oncol,2005,23(16s):3524.
  • 9Ahn J,Jung KH,Park YS,et al.Phase Ⅱ trial of irinotecan and capecitabine in patients with advanced colorectal cancer (ACRC) (Abstr)[J].J Clin Oncol,2005,23(16s):3714.
  • 10Grothey A,Jordan K,Kellner O,et al.Randomized phase Ⅱ trial of capecitabine plus irinotecan(Caplri)versus capecitabine plus oxaliplatin (CapOx) as first-line therapy of advanced colorectal cancer(ACRC)(abstr)[J].Proc Am Soc Clin Oncol,2003,22:1022.

共引文献12

同被引文献9

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部